Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients

Transplant Proc. 1993 Feb;25(1 Pt 2):1122-3.

Authors

J Stephens¹, R Goldstein, J Crippin, B Husberg, M Holman, T A Gonwa, G Klintmalm

Affiliation

¹ Transplantation Service, Baylor University Medical Center, Dallas, Texas 75246.

PMID: 7680144

No abstract available

MeSH terms

Azathioprine / therapeutic use
Cholangitis, Sclerosing / complications
Cholangitis, Sclerosing / surgery*
Colitis, Ulcerative / complications
Colitis, Ulcerative / physiopathology
Crohn Disease / complications
Crohn Disease / physiopathology
Cyclophosphamide / therapeutic use
Cyclosporine / therapeutic use
Female
Graft Rejection / therapy
Humans
Immunosuppressive Agents / therapeutic use*
Inflammatory Bowel Diseases / complications
Inflammatory Bowel Diseases / physiopathology*
Liver Transplantation / immunology
Liver Transplantation / physiology*
Male
Middle Aged
Muromonab-CD3 / therapeutic use
Retrospective Studies
Steroids / therapeutic use
Tacrolimus / therapeutic use

Substances

Immunosuppressive Agents
Muromonab-CD3
Steroids
Cyclosporine
Cyclophosphamide
Azathioprine
Tacrolimus